Promoting evidence-based policy discussions and protecting ashwagandha
There is a large body of scientific evidence, including clinical trials and pre-clinical studies that demonstrate both ashwagandha root and leaf are safe, effective and
non-toxic.
What is ashwagandha?
Ashwagandha is a botanical with a 3,000-year history in traditional Indian medicine. Over the last number of decades it has been used in food supplements in the US, Europe, Canada and Australia.
The roots and leaves of the products have been shown in clinical trials to deliver a wide range of health benefits, which can help to support the health of thousands of Europeans.
Modern peer-reviewed research has repeatedly found that ashwagandha root and leaf can support public health:
Reduces Stress & Anxiety
Enhances Sleep Quality
Reduces Inflammation
Improves Cognative Function
Reduces Menopausal Symptions
Why safeguard ashwagandha?
As discussions around botanical regulation evolve, steps must be taken to ensure continued access to science-backed supplements like ashwagandha.
Some European countries are in the process of regulating ashwagandha and it’s important that a sustainable framework is developed that guarantees consumer safety and continued access to this beneficial botanical.
Providing policymakers with the latest clinical and peer-reviewed scientific data supports regulators to make evidence-based decisions on ashwagandha.
Concerningly misinformation about ashwagandha is widespread leading to unsubstantiated concerns around its safety.
Recommendations to safeguard ashwagandha
Scientific Evaluation
Encourage policymakers to conduct a full review of the scientific literature and clinical trial data on ashwagandha’s safety to ensure policy decisions are based on the latest and highest-quality scientific evidence.
Clear Usage Guidance
The use of cautionary labels on ashwagandha products would help to ensure consumer safety for potentially vulnerable groups where insufficient scientific data is available.
Standardisation
Greater product standardisation will give consumers and regulators greater confidence in the contents and levels of active compounds in ashwagandha products.
Transparency
Increased reporting requirements about the contents of ashwagandha products will help to remove potentially substandard or contaminated products from the market.
Further Research
We urge the industry to conduct additional clinical trials and pre-clinical studies to further rule out any potential concerns around ashwagandha use.
Do you want to protect access to ashwagandha and ensure that any future regulation is evidence-based?
Join our campaign and stay up to date on the latest scientific research on ashwagandha and our advocacy efforts.
JOIN US